Telomere-mediated mitotic disturbances in immortalized ovarian epithelial cells reproduce chromosomal losses and breakpoints from ovarian carcinoma

被引:36
作者
Gisselsson, D [1 ]
Lv, M
Tsao, SW
Man, C
Jin, C
Höglund, M
Kwong, YL
Jin, YS
机构
[1] Univ Lund Hosp, Dept Clin Genet, SE-22185 Lund, Sweden
[2] Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Dept Anat, Fac Med, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
10.1002/gcc.20094
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian carcinomas (OCs) often exhibit highly complex cytogenetic changes. Abnormal chromosome segregation at mitosis is one potential mechanism for genomic rearrangements in tumors. In this study, OCs were demonstrated to have dysfunctional short telomeres, anaphase bridging, and multipolar mitoses with supernumerary centrosomes. When normal human ovarian surface epithelial (HOSE) cells were transfected with human papilloma virus 16 e6/e7 genes and subsequently driven into telomere crisis, the same set of mitotic disturbances occurred in a distinct sequence, initiated by telomere dysfunction, followed by anaphase bridging, and then supernumerary centrosomes and multipolar mitoses. The anaphase bridges resolved either by kinetochore-spindle detachment, corresponding to whole-chromosome losses in the HOSE karyotypes, or by extensive fragmentation of intercentromeric DNA sequences, corresponding to a high frequency of pericentromeric rearrangements. At later passages, the high degree of instability at telomere crisis was moderated by telomerase expression and centrosome coalescence, ultimately leading to a level of mitotic instability that was highly similar to that in OC cell lines and to complex karyotypes that were similar to those observed in high-grade OCs. This suggests that a significant proportion of the structural chromosome changes and genomic losses in OC are caused by a specific sequence of mitotic disturbances triggered by telomere crisis. That the model did not produce any of the whole-chromosome gains observed in OC indicates that these changes develop through a different mechanism. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:22 / 33
页数:12
相关论文
共 36 条
[1]   Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice [J].
Artandi, SE ;
Chang, S ;
Lee, SL ;
Alson, S ;
Gottlieb, GJ ;
Chin, L ;
DePinho, RA .
NATURE, 2000, 406 (6796) :641-645
[2]   Ovarian cancer: Changes in patterns at diagnosis and relative survival over the last three decades [J].
Barnholtz-Sloan, JS ;
Schwartz, AG ;
Qureshi, F ;
Jacques, S ;
Malone, J ;
Munkarah, AR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (04) :1120-1127
[3]   REACTIVITY OF A MONOCLONAL-ANTIBODY WITH HUMAN OVARIAN-CARCINOMA [J].
BAST, RC ;
FEENEY, M ;
LAZARUS, H ;
NADLER, LM ;
COLVIN, RB ;
KNAPP, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (05) :1331-1337
[4]   The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle [J].
Duensing, S ;
Lee, LY ;
Duensing, A ;
Basile, J ;
Piboonniyom, S ;
Gonzalez, S ;
Crum, CP ;
Münger, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (18) :10002-10007
[5]  
Duensing S, 2002, CANCER RES, V62, P7075
[6]   ABSENCE OF HELA-CELL CONTAMINATION IN 169 CELL LINES DERIVED FROM HUMAN TUMORS [J].
FOGH, J ;
WRIGHT, WC ;
LOVELESS, JD .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1977, 58 (02) :209-214
[7]  
Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.3.CO
[8]  
2-G
[9]   Centrosomal abnormalities, multipolar mitoses, and chromosomal instability in head and neck tumours with dysfunctional telomeres [J].
Gisselsson, D ;
Jonson, T ;
Yu, C ;
Martins, C ;
Mandahl, N ;
Wiegant, J ;
Jin, Y ;
Mertens, F ;
Jin, C .
BRITISH JOURNAL OF CANCER, 2002, 87 (02) :202-207
[10]   Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors [J].
Gisselsson, D ;
Jonson, T ;
Petersén, Å ;
Strömbeck, B ;
Dal Cin, P ;
Höglund, M ;
Mitelman, F ;
Mertens, F ;
Mandahl, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (22) :12683-12688